Wells Fargo & Company Takeda Pharmaceutical CO LTD Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Wells Fargo & Company holds 863,678 shares of TAK stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

863,678

Previous 978,002 11.69%

Holding current value

$12 Million

Previous $13.9 Million 17.72%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$13.01 - $14.43 $1.49 Million - $1.65 Million	-114,324 Reduced 11.69%	863,678 $11.4 Million
Q3 2024 Nov 13, 2024	BUY	$13.0 - $15.08 $1.38 Million - $1.6 Million	106,335 Added 12.2%	978,002 $13.9 Million
Q2 2024 Aug 13, 2024	BUY	$12.6 - $13.67 $261,097 - $283,269	20,722 Added 2.44%	871,667 $11.3 Million
Q1 2024 May 10, 2024	BUY	$13.89 - $15.04 $1.06 Million - $1.15 Million	76,393 Added 9.86%	850,945 $11.8 Million
Q4 2023 Feb 09, 2024	BUY	$13.36 - $15.43 $170,420 - $196,825	12,756 Added 1.67%	774,552 $11.1 Million
Q3 2023 Nov 13, 2023	BUY	$15.03 - $16.32 $41,272 - $44,814	2,746 Added 0.36%	761,796 $11.8 Million
Q2 2023 Aug 15, 2023	SELL	$15.57 - $17.11 $2.11 Million - $2.32 Million	-135,409 Reduced 15.14%	759,050 $11.9 Million
Q1 2023 May 12, 2023	SELL	$15.28 - $16.48 $546,458 - $589,374	-35,763 Reduced 3.84%	894,459 $14.7 Million
Q4 2022 Feb 13, 2023	BUY	$12.42 - $15.62 $585,379 - $736,201	47,132 Added 5.34%	930,222 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $113,804 - $254,727	8,891 Added 1.02%	883,090 $11.5 Million
Q2 2022 Aug 12, 2022	BUY	$13.12 - $15.03 $714,593 - $818,623	54,466 Added 6.64%	874,199 $12.3 Million
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $13 Million - $14.7 Million	-956,805 Reduced 53.86%	819,733 $11.7 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $5.91 Million - $7.36 Million	-448,517 Reduced 20.16%	1,776,538 $24.2 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $710,712 - $752,570	-43,602 Reduced 1.92%	2,225,055 $36.4 Million
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $4.15 Million - $4.67 Million	-250,614 Reduced 9.95%	2,268,657 $38.2 Million
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $1.78 Million - $2.12 Million	106,576 Added 4.42%	2,519,271 $46 Million
Q4 2020 Feb 09, 2021	BUY	$15.39 - $18.97 $12.8 Million - $15.8 Million	833,987 Added 52.83%	2,412,695 $43.9 Million
Q3 2020 Nov 05, 2020	BUY	$17.1 - $19.19 $5.7 Million - $6.4 Million	333,298 Added 26.76%	1,578,708 $28.2 Million
Q2 2020 Aug 13, 2020	BUY	$14.59 - $19.5 $13.1 Million - $17.5 Million	896,489 Added 256.93%	1,245,410 $22.3 Million
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $4.54 Million - $7.09 Million	348,921 New	348,921 $5.3 Million

Others Institutions Holding TAK

# of Institutions

338

Shares Held

68.6M

Call Options Held

1.72M

Put Options Held

178K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Takeda Pharmaceutical CO LTD Transaction History